Mabion S Ais A Biopharmaceutical Company Based In Polandspecializing In The Development Of Biotech Drugs Using Monoclonal Antibody Technologyfounded In 2009 And Headquartered In Konstantyna3W Aa3Dzkithe Company Operates As A Contract Development And Manufacturing Organizationcdmo Mabion Provides A Wide Range Of Servicesincluding Protein Expression Technologiespurification Of Biologicsgmp Standard Manufacturingand Analytical Tools Developmentthey Also Support Clinical Development And Regulatory Activities To Ensure Compliance Throughout The Drug Development Process Mabion Focuses On The Production Of Biologicsparticularly Monoclonal Antibodiesand Offers Both Active Substances And Finished Products For Pharmaceutical Applicationsthe Company Has Reported Significant Financial Performancewith Revenues Around Pln 110 79 Million And A Net Income Of Pln 10 24 Millionmabion Aims To Strengthen Its Position In The Global Market By Providing Comprehensive Services From Early Stage Discovery To Commercial Manufacturing
Bio International Convention 2025
United States
16 Jun 2025
2445
Cphi Frankfurt
Germany
28 Oct 2025
4.1
L48
| Company Name | Mabion Sa |
| Country |
Poland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
